Amanote Research
Register
Sign In
Endothelin ETA Receptor Antagonist Blocks Cardiac Hypertrophy Provoked by Hemodynamic Overload
Circulation
- United States
doi 10.1161/01.cir.89.5.2198
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cardiovascular Medicine
Physiology
Cardiology
Date
May 1, 1994
Authors
H Ito
M Hiroe
Y Hirata
H Fujisaki
S Adachi
H Akimoto
Y Ohta
F Marumo
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related search
Effects of the Endothelin ETA-Receptor Antagonist FR139317 on Development of Hypertension and Cardiovascular Hypertrophy in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
The Japanese Journal of Pharmacology
Quercetin Prevents Cardiac Hypertrophy Induced by Pressure Overload in Rats
Journal of Veterinary Medical Science
Veterinary
ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension
Hypertension
Internal Medicine
The Effects of Ambrisentan, a Selective Endothelin ETA Receptor Antagonist for Vasogenic Edema After Traumatic Brain Injury in Mice
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Endothelin ETA Receptor Expression in Human Cerebrovascular Smooth Muscle Cells
British Journal of Pharmacology
Pharmacology
Endothelin-A Receptor Antagonist Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Small Heterodimer Partner Blocks Cardiac Hypertrophy by Interfering With GATA6 Signaling
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Endothelin Antagonist Reduces Hemodynamic Responses to Vasopressin in DOCA-salt Hypertension
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
A Novel ETA-receptor Antagonist, FR 139317, Inhibits Endothelin-Induced Contractions of Guinea-Pig Pulmonary Arteries, but Not Trachea
British Journal of Pharmacology
Pharmacology
